Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • Power of Women 2024
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Tuberculosis

Trump’s HIV funding cuts will also hit diabetes, cervical cancer and depression hard
Health
/ 27 May 2025

Trump’s HIV funding cuts will also hit diabetes, cervical cancer and depression hard

As government clinics take on HIV patients who were previously treated by Pepfar-funded projects, the treatment of conditions like diabetes and heart disease will come under pressure

By Zano Kunene
The US’s NIH funds R6.65 billion of research in South Africa
Health
/ 30 April 2025

The US’s NIH funds R6.65 billion of research in South Africa

If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity

By Linda Pretorius and Jacques Verryn
Trump ends SA’s HIV and TB research grants
Health
/ 24 March 2025

Trump ends SA’s HIV and TB research grants

Cancellation letters, which end millions of rands of South African universities’ US-government funded HIV and TB research grants with immediate effect, started to roll in over the weekend

By Mia Malan
In wake of US cuts, SA must step up to protect LGBTIQ+ rights in Africa
Thought Leader
/ 20 March 2025

In wake of US cuts, SA must step up to protect LGBTIQ+ rights in Africa

The suspension and withdrawal of US support for people’s rights in Africa is a setback

By Gibson Ncube
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
Health
/ 5 March 2025

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support

By Ida Jooste
Trump’s cuts show the need to democratise reproductive health funding
Thought Leader
/ 28 February 2025

Trump’s cuts show the need to democratise reproductive health funding

Sources that are unrestricted, aligned with South African law and human rights, and without political interference, must be found as an alternative to the US

By Duduetsang Mmeti and Sesona Buyeye
Why SA needs to get a grip on diabetes – fast
Health
/ 18 February 2025

Why SA needs to get a grip on diabetes – fast

About 60 000 South Africans die in a year from diseases that are not caused by tuberculosis or HIV before they turn 70, and about a fifth of these are from diabetes

By Zano Kunene
Trump’s funding cuts hit HIV, GBV services hard
Health
/ 15 February 2025

Trump’s funding cuts hit HIV, GBV services hard

The US president’s cutting of financial support has cut life-saving treatment for many in SA

By Umamah Bakharia
Some Pepfar projects can now restart in full, without a waiver
Health
/ 13 February 2025

Some Pepfar projects can now restart in full, without a waiver

A federal judge has enforced a temporary restraining order blocking Donald Trump from freezing federal grants

By Mia Malan
UPDATE | Embassy confirms Pepfar projects will restart, despite Trump aid ban
Health
/ 11 February 2025

UPDATE | Embassy confirms Pepfar projects will restart, despite Trump aid ban

Such programmes still qualify for a limited waiver, which will expire towards the end of April, but only for approved activities

By Mia Malan
Ramaphosa reaffirms NHI commitment but is silent on private medical aids
Health
/ 6 February 2025

Ramaphosa reaffirms NHI commitment but is silent on private medical aids

In his 2025 State of the Nation address the president promised improved healthcare access and infrastructure

By Mandisa Nyathi
The biophotonic breakthrough
Partner Content
/ 12 July 2024

The biophotonic breakthrough

Prof Patience Mthunzi-Kufa’s work illuminates the future of healthcare

By Jamaine Krige
New responses to diseases – and each other
Opinion
/ 17 May 2024

New responses to diseases – and each other

Antagonism and tension are inherent in our being but we can change the conversation

By Skye Scott
Rural KwaZulu-Natal is helping the world find a TB vaccine
Health
/ 16 April 2024

Rural KwaZulu-Natal is helping the world find a TB vaccine

Despite being a preventable and curable disease, about 150 people died from TB every day in South Africa in 2022

By Sipokazi Fokazi
Africans can solve TB, the disease that haunts us. Here’s how
Opinion
/ 24 March 2024

Africans can solve TB, the disease that haunts us. Here’s how

Africans need to be fully involved in drug discovery and development research for tuberculosis on the continent

By Khisimuzi Mdluli
From start to finish: Five lessons for making mRNA jabs for TB
Health
/ 21 November 2023

From start to finish: Five lessons for making mRNA jabs for TB

The need for a new tuberculosis vaccine is as urgent as ever, and now a local pharmaceutical company is joining the race to find one

By Zano Kunene
Will Earth’s changing climate make TB spread faster?
The Green Guardian
/ 13 October 2023

Will Earth’s changing climate make TB spread faster?

By 2030, the planet is likely to be warmer, undermining the fight against tuberculosis

By Linda Pretorius and Nicole Ludolph
TB talks: Will #UNGA78 change these three lives?
Health
/ 26 September 2023

TB talks: Will #UNGA78 change these three lives?

In the past five years, none of the targets political leaders adopted after the previous round of high-level discussions on the fight against tuberculosis at the United Nations General Assembly have been met

By Nicole Ludolph and Bhekisisa Team
Kingdom of Lesotho Ministry of Health – Request for Expression of Interest – TB Consultant
Partner Content
/ 24 August 2023

Kingdom of Lesotho Ministry of Health – Request for Expression of Interest – TB Consultant

Terms of References for the Preparation of the Lesotho Project Implementation Completion Report

By Special Reports
M72: Three things you need to know about a TB jab that might work
Health
/ 25 July 2023

M72: Three things you need to know about a TB jab that might work

The only anti-tuberculosis shot we have is the century-old BCG vaccine given to infants, whose protection only lasts for 10 to 20 years

By Lillian Roberts
Can taking two pills a week slow down TB in South Africa?
Health
/ 18 July 2023

Can taking two pills a week slow down TB in South Africa?

Nhe new guidelines say anyone who has a big chance of getting infected can get access to preventive medicines

By Nicole Ludolph
The keys to solving the legacy issues in SA’s mining sector
Opinion
/ 20 April 2023

The keys to solving the legacy issues in SA’s mining sector

The goal of ‘zero harm’ has seen progress but is yet to be fully realised

By Busisipho Siyobi
Should you be worried about asymptomatic TB?
Health
/ 3 April 2023

Should you be worried about asymptomatic TB?

More than half of people in South Africa with tuberculosis may not know it, because they don’t have symptoms such as coughing and weight loss

By Joan Van Dyk
African rats are being used to sniff out wildlife crime
The Green Guardian
/ 15 March 2023

African rats are being used to sniff out wildlife crime

Two nonprofits are training African giant pouched rats to detect smuggled contraband in shipping containers

By Sheree Bega
Mine fatalities at a record low in 2022
National
/ 31 January 2023

Mine fatalities at a record low in 2022

The reduction of deaths from falls of ground accidents is significant, because this usually contributes the most to total mine fatalities

By Anathi Madubela
Africa can improve TB treatment – all it needs is political will
Opinion
/ 14 November 2022

Africa can improve TB treatment – all it needs is political will

There has been progress in some countries but it’s still a long way off from curtailing tuberculosis on the continent

By Morounfolu Olugbosi
WATCH: How to keep teenagers on tuberculosis treatment
Health
/ 4 October 2022

WATCH: How to keep teenagers on tuberculosis treatment

TB was the leading cause of teenage deaths between 2008 and 2018 in South Africa

By Joan Van Dyk and Dylan Bush
Is the future of South Africa’s tuberculosis (TB) plans locked up in the mysterious minds of teens?
Health
/ 20 September 2022

Is the future of South Africa’s tuberculosis (TB) plans locked up in the mysterious minds of teens?

Researchers struggle to understand how teenagers experience tuberculosis treatment, and they haven’t done enough to ask, experts at last week’s seventh South African TB conference argued

By Joan Van Dyk
The oldest trick in Big Tobacco’s playbook nearly derailed South Africa’s TB conference. Here’s why
Opinion
/ 13 September 2022

The oldest trick in Big Tobacco’s playbook nearly derailed South Africa’s TB conference. Here’s why

The Foundation for Professional Development accepted a R2-million research grant from an organisation that’s regarded as a front for Philip Morris International

By Joan Van Dyk
The Covid-19 lockdown tore apart the TB safety net
Opinion
/ 30 March 2022

The Covid-19 lockdown tore apart the TB safety net

Five years of progress in the fight against TB have been eliminated because of the pandemic

By Morounfolu Olugbosi
Tuberculosis: South Africa’s forgotten killer
Health
/ 15 March 2022

Tuberculosis: South Africa’s forgotten killer

Sidelined during the Covid-19 pandemic, the country’s deadliest disease has been working under cover

By Dennis Webster
Campaign against patent laws ‘causing barriers’ to life saving Covid-19, TB, HIV and cancer drugs
Health
/ 10 November 2021

Campaign against patent laws ‘causing barriers’ to life saving Covid-19, TB, HIV and cancer drugs

The Fix The Patent Laws Campaign wants Trade Minister Ebrahim Patel to publish amendments to the Patent Act to make all medication affordable

By Eyaaz Matwadia
← Older posts

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }